ABSTRACT
INTRODUCTION
Mesenchymal stem cells (MSCs) are heterogeneous population of multipotent and committed progenitor cells that are typically characterized by their ability to differentiate along a well-defined lineage including osteoblasts, chondrocytes, adipocytes, muscle cells, pericytes, reticular fibroblasts, and even neural cells [1] [2] [3] [4] . A major source of these cells is the bone marrow and previous studies have shown the presence of MSCs in tissues other than the bone marrow such as dental pulp and adipose tissue as well. [5, 6] . Bone marrow derived human mesenchymal stem cells (BM-hMSCs) represent an appealing source of adult stem cells for cell therapy and tissue engineering, as they are easily obtained and expanded in vitro while maintaining their multilineage differentiation potential [7, 8] . BM-MSCs can be expanded in vitro without any apparent modification in phenotype or loss of function [9] . The potential use of MSCs has been reported in clinical trials that are focused on treating several diseases such as myocardial infarction, stroke, Crohn's disease, and diabetes [10] .
MSCs can also differentiate into non-mesodermal lineage such as neural cells mediated by various inducers such as cytokines, cerebrospinal fluid and micro RNAs (miRNA) [1, [11] [12] [13] . Previous studies have shown the neuronal differentiation capability of rat, mouse and human derived MSCs with combination of chemicals or growth factors [13] . Cytokines, growth factors, neurotrophins and retionic acid can be used to promote and support neuronal differentiation [14] . For example, when mouse marrow stromal cells were treated with epidermal growth factor (EGF) and brain derived neurotrophic factor (BDNF), neuronal markers such as NeuN and MAP-2 were detected [13] .
Potent chemical reagents used for neural induction are 3-Isobutyl-1-Methylxanthine (IBMX), dibutyryl cyclic adenosine monophosphate (dbcAMP) and dimethylsulfoxide (DMSO) [9, 15] . These reagents without any growth factor addition provide only rapid neuron-like morphology acquisition [1] . Other neural induction candidates, neurotrophic factors, are essential polypeptide hormones for the development and the maintenance of the central nervous system. Neurotrophins (brain derived neurotrophic factor; BDNF, nerve growth factor; NGF and neurotrophin 3; NT-3, neurotrophin 4/5; NT-4/5), have the potential to contribute to the processes of neural fate in the stages through neurogenesis and neuroprotection. BDNF plays role in the development and maintenance of neuronal populations while NGF is also required for the development and survival of neurons [16, 17] . BDNF is also involved in neurite outgrowth by binding TrkB receptor and regulates axonal and dendritic morphology [18] . Neuronal phenotype is enhanced when cytokines are enriched in neural induction media [19] . One of the major limitations in neural induction methods is the complications about neuronal phenotype, cytotoxicity of induction cocktail and insufficient functional ability of neurons [20] . Only few studies have shown that hMSC-derived neurons are functionally active upon chemical or electrical excitation [21] . Because of the complexity of the nervous system, prior to use hMSC derived neurons as a tool for disease modeling or regenerative applications, the activity pattern and functional synapse formations of these neurons have to be defined to move the neuronal differentiation study a step further [22] [23] [24] .
In this study we demonstrated the ability of bone marrow hMSC derived neurons to generate spontaneous activity and respond to electrical stimulation. Herein, we introduce hMSC-derived neurons (hMd-Neurons) with high functional neuronal ratios in a defined induction media that can be further studied and potentially link the technical bridges to broadly study the nervous system deficiencies.
MATERIALS and METHODS

Cell lines and Reagents
Human bone marrow derived mesenchymal stem cell (hMSC) line (UE7T-13 cells, no. RBRC-RCB2161; RIKEN, Japan) [20, [25] [26] [27] [28] , Growing and expansion media of hMSCs: Dulbecco's Medified Eagle's Medium (DMEM; Gibco) with 2mM L -Glutamine, Fetal bovine serum (FBS; Gibco), Penicillin/Streptoycin (Gibco). Neuronal induction: dibutyryl cyclic AMP (dbcAMP; Sigma), 3-isobutyl-1-methylxanthine (IBMX; Sigma), human epidermal growth factor (hEGF; Sigma), recombinant human basic fibroblast growth factor (bFGF; R&D systems), fibroblast growth factor-8 (FGF-8; Pepro Tech), recombinant human brain-derived neurotrophic factor (BDNF; R&D systems), and nerve growth factor (NGF), Neurobasal medium (Gibco) supplemented with 2% B27 supplement (Gibco), 2 mM L-glutamine (Gibco).
Sample collection and ethical issues
Human bone marrow aspirates of healthy donors were supplied by Istanbul Medipol University, Center for Bone Marrow Transplantation. Bone marrow samples (n=5, 1 female and 4 males) were collected from healthy donors from ages 2-18 and used in this study. Written consents of donors (parents of the matched allogeneic donors) were obtained, documented and witnessed. While doing the harvesting of the bone marrow for transplantation, 20 ml/ kg of donor bone marrow was harvested ( 400-1000 ml) and 5 ml was kept for the study. The 395-995 ml was infused to the patient. All procedures were approved by Ethics Committee of Author University. 
Isolation and Expansion of Bone Marrow Mesenchymal Stem Cells
Human mesenchymal stem cells (hMSCs) were isolated from bone marrow by ficoll density gradient centrifugation. After isolation, cells were cultured in Dulbecco's Modified Eagle Medium-low glucose (DMEM-LG, Gibco) culture medium containing 20% fetal bovine serum (FBS, Gibco) and 0.2 % primocin (Gibco). Cells were incubated at 37 o C in a humidified 5% CO 2 chamber. Then, non-adherent cells were removed via medium refreshment after 3 days (d) and adherent cells were labeled as passage 0 (P0) and grown to 80% confluence. When the cells reached 80% confluence, they were detached with 0,25 % Trypsin/EDTA solution. The cells were harvested and subcultured at a density of 1.5 x10 3 cells/cm 2 in culture flasks per [5] [6] days. Flow cytometry analysis was performed at passage 3 (P3) and each donor derived hMSCs were processed in the same order and used for all experiments.
Flow Cytometry
To confirm hMSC phenotype of isolated cells grown in culture, cells were subjected to flow cytometry analysis. Flow cytometry was performed using a FACS (BD Influx Cell Sorter with Bioprotect IV Safety Cabinet) system. The data were analysed with 
Mesodermal Differentiation
To qualify isolated cells from BM as MSCs, cells were induced for differentiation into adipogenic, osteogenic and chondrogenic lineages. Briefly, for adipogenic differentiation, 5x10 3 
Neuronal Induction
For neural induction experiments, we used a commercial hMSC cell line (UE7T-13 cells, no. RBRC-RCB2161; RIKEN, Japan) and hMSCs isolated from 5 different healthy donors. We repeated experiments for each hMSC donors used in this study.
hMSCs at P3 were seeded on culture dishes prior to neuronal induction. Cell density was optimized to 3,0x10 3 . Culture was maintained via using DMEM containing 10% FBS and cells were incubated in 37 o C, 5% CO 2 incubator for 24 hrs. Neuronal induction media was prepared with 20 ng/ml hEGF, 40 ng/ml bFGF, 10 ng/ml FGF-8, 10 ng/ml human BDNF, 40 ng/ml NGF, 0.125 mM dbcAMP, 0.5 mM IBMX, 2 mM Lglutamine in Neurobasal medium + B27 supplement in the absence of serum. Cells were then treated with neuronal induction media by medium refreshment every 48 hours throughout the differentiation process. In line with this, samples were collected for reverse transcriptase PCR (RT-PCR) at distinct time points (d0, d2, d6, and d12).
Time Dependent Cell Response Profiling (RT-CA)
We used a real time cell analysis system, xCELLigence RT-CA (Roche) to monitor motility of hMSCs. The system detects impedence changes within multiwells that contain electrode arrays at the bottom (E-plates). As the culture cells multiply, this increases impedence and an upward deflection is recorded in the cell index.
Therefore, proliferating and migrating hMSCs show an increasing cell index, while neuronal differentiated hMSCs are expected to display stable cell index related to their decreased motility. Before starting the experiments background readings were made by culture medium only. Then, 3x10 3 hMSCs were added to each well in expansion medium, which was replaced with the neuronal induction medium 24 hours later. The induction medium was replaced every 48 hours. The E-Plates containing the cells were placed on the reader in 37 o C, 5% CO 2 incubator for cell index recording for 12 days. 
Cell Viability Assays
Reverse Transcriptase PCR (RT-PCR)
RNA samples of hMSC were extracted by using RNeasy kit (Qiagen). 0.5 µg of total RNA was reverse transcribed to obtain cDNA by Quantitect Reverse Transcription kit 
Calcium imaging
Statistics
Statistical comparisons were performed by t-test and/or two-tailed t-test assuming equal variance. Differences were considered as statistically significant at p *** < 0.0001. Data are the mean ± standard error (SE). One-way analysis of variance (ANOVA) was used to evaluate the differences in cell death levels among three
groups. An alpha value of p # < 0.05 was used for statistical significance.
RESULTS
Functional neurons (hMd-Neurons) can be yielded with high ratios from hMSCs in vitro
To study neuronal differentiation of hMSCs, we initially used human bone marrow hMSC cell line (UE7T-13 cells, no. RBRC-RCB2161; RIKEN, Japan) [20, [25] [26] [27] [28] . To improve in vitro generation of neuronal cells with sufficient differentiation capacity, we used a non-viral neuronal induction method which is an enriched form of previously defined combination [19] . Neuronal cell morphology was observed within 24hrs upon neuronal induction (NI) and almost all hMSC cell line gave rise to bipolar neuron-like cells with neuritis (Fig. 1A) . folds respectively (c', f'). Scale bars represent 50 μm.
Isolated cells from healthy bone marrow donors represent hMSC phenotype
After yielding functional neurons from hMSC cell line, we then studied neuronal differentiation of hMSCs from healthy human bone marrow donors in detail. We first showed that cells isolated from human bone marrow are MSCs in agreement with the criteria of International Society for Cellular Therapy published in 2006 [7] . During initial phases of culture, non-adherent cells were depleted and very small proportion of the cells attached on plastic culture surface. These cells had a fibroblast-like morphology, formed colonies and by passage 3 (P3), more than 95% of the cells were MSCs as revealed by flow cytometry analyses. Results from different healthy donors indicated that these adherent cells at P3 have hMSC immunophenotype with negative expression of CD45, CD34, CD14 and CD31 while they were positive for CD29, CD44, CD73, and CD105 ( Fig. 2A, B) . while the former stains calcium deposits indicative of mineralization, the latter turns chondrogenic spheroids into dark blue which marks the extracellular matrix of cartilage (Fig. 2C) . Positive stainings were counted for each from 10 different independent fields and the differentiation percentages were then determined.
Depending on 50% chondrogenic, 43% osteogenic and 52% adipogenic differentiation rates, we concluded that more than 95% of the cells from bone marrow were hMSCs at P3 in our experimental paradigm.
Donor derived hMSCs can also differentiate into hMd-Neurons
We maintained NI for 12 days prior to phenotypical/functional characterization of neuronal induced hMSCs from bone marrow donors and their neuronal morphology in culture was variable (Fig. 3A) . Morphologically neural like cells with neurite extensions were counted from 10 different independent fields and the neural morphology percentages were then determined. On one hand, hMSCs derived from bone marrow donors showed neural morphology (65%) at day 1 of NI while neuronal cell percentage was increased to 80% by day 3 ( Figure 3S-a, b) . We determined the highest proportion of neural cells from hMSC donors as 85% at day 5 ( Figure S3 ), which slightly increased up to 90-95% at day 12 ( Fig. 3B) . 99±2%, 99±2% and 99.5±1% of hMSCs were apoptotic in CAM group at day 2, 6 and 12, respectively. In the uninduced group 1±0.8% and 15±2% apoptotic cells were observed only at day 6 and day 12. In contrast, a no significant number of apoptotic cells were observed in NI group at any time point (Fig. 3C, D) . Next, we investigated cell kinetics of differentiated versus undifferentiated hMSCs by real time cell analysis depending on cel motility changes (named as cell index) (XCelligence, Roche). The recordings suggest that the number of uninduced hMSCs incresad steadily while hMd-Neurons showed a stable cell index by day2 of NI. In addition to that, cell index was stabilized around day 6 of NI at which cells might commit to attain neuronal characteristics (Fig. 3E) .
As a phenotypical outcome of neuronal differentiation, we assessed neuronal transcripts of βIII Tubulin, Nestin, NSE, NF, and a housekeeping gene (GAPDH). RT-PCR results indicated that donor derived hMd-Neurons have transcripts of early neuronal marker NSE by day 2 and late neuronal marker NF by day10. Transcripts of βIII Tubulin and Nestin were detected during all stages of differentiation. However, uninduced hMSC also had βIII Tubulin and Nestin mRNAs (Fig. 3F) , which has also been previously reported [15] [16] [17] 30] . Next, we showed neuronal protein expressions on donor-derived hMd-Neurons on day 12 of neuronal induction (NI) by immunofluorescence staining. More than 90% of hMd-Neurons showed expressions of neuronal markers NF, NeuN, NSE, PGP 9.5, as well as synaptic proteins Synaptophysin, and PSD 95 (Fig. 3G, H) .
hMSCs preserve Nestin whereas they loose Ki-67 and Sox-2 expression during differentiation into hMd-Neurons
To examine the differentiation process of hMd-Neurons, we evaluated the fractions of Nestin and Sox-2 positive cells in hMd-Neurons at day 6. We also included Ki-67 as a marker for proliferating cells. Flow cytometry analysis (single channel) showed that among hMd-Neurons from healthy donors 99% were Nestin positive; 96% of cells were Ki-67 and Sox-2 negative (Fig. 3I) . Accordingly, multichannel records revealed that almost 90% of Nestin positive cells were Sox-2 and Ki-67 negative whilst Nestin positive (Fig. 3J ). This data correlated with the presence of Nestin transcripts during neuronal differentiation (Fig. 3F) . Assembly of data from mature protein expressions and lack of neural stem cell and proliferation markers suggests that phenotype of hMd-Neurons by day 6 is a neuronal cell type rather than a neural stem/progenitor cell type.
hMd-Neurons from healthy bone marrow donors mature into both electrophysiologically and spontaneously active neurons
To study functionality of hMd-Neurons from health bone marrow donors, we stained their in vitro neuronal connections for presynaptic (Synaptophysin) and postsynaptic (PSD95) proteins and they were positive for both synaptic markers (Fig. 4A) . Images were taken under 20X.
We then evaluated their Ca ion flux as we demonstrated for hMSC cell line derived hMd-Neurons. We recorded spontaneous activity of donor-derived hMd-Neurons through Ca ion imaging (Fig. 4B , Figure S4 and Video 2 and Video 3). No activity was detected from uninduced hMSCs (Video 4). Donor derived hMd-Neurons showed individual differences in terms of firing frequencies (average was twice in less than 1 minute) (Fig. 4C) . Among all hMd-Neurons, around %75 were spontaneously active neurons (Fig. 4D ).
In addition to Ca ++ imaging, we evaluated neuronal functionality by patch clamp technique. Prior to experiments we cultured hMd-Neurons for 18 days to let maturation of their electrical properties. We also recorded directly from donor-derived hMd-Neurons to characterize their electrophysiological properties. We applied electrical stimulation to activate the cells and then hMd-Neurons generated action potentials upon electrical stimulation in miliseconds similar to a maturating neuron (Fig. 4E) . We also showed that hMd-Neurons could survive as monolayers over long periods in NI media without the addition of any extracellular matrix proteins or coating materials (Fig. 4F ).
DISCUSSION
One of the main concerns about studies with neuronal differentiation of hMSCs is establishing a succesful induction method leading to sustainable and high yields of functional neurons [31] . In this study, we showed that bone marrow hMSCs either from cell line or healthy donors differentiate into functional neurons (>74%) by a single step protocol. hMSC derived neurons (hMd-Neurons) displayed spontaneous activity and showed response in miliseconds to electrical stimulation as a typical maturating neuron [32] . We then monitored Calcium ion exchange to determine activity of hMd-Neurons. Surprisingly, we could detect spontaneous activity of hMd-Neurons both from hMSC cell line and donor derived hMSCs without any stimulatory chemical addition [34] [35] [36] . This is a phenomenon that can be discussed since spontaneous activity is not an ability of all primary neurons. For instance, when Calcium ion imaging applied, mouse derived dorsal root ganglia (DRG) neurons are quiescent (no activity) while cortical neurons display firing pattern spontaneously even at high frequencies [37, 38] . [39] . Additionally, improvement of the culture conditions using tissue engineering tools, which mimicks neuronal microenvironment can be applied to study maturation process of hMd-Neurons thoroughly. These studies will maximize to understand abilities of hMd-Neurons to form functional neural networks and this is an avenue that we are actively pursuing. [40] [41] [42] . One solution to that might be investigation of hMSC subpopulations that have the potential to differentiate into a specific neuron type with high purity under certain conditions. Similar approach was previously reported to successfully yield neurons from Nestin positive hMSCs [43, 44] . Adopting it to obtain function/tissue specific neurons from hMSC subtypes can be a clonogenic based approach for neural differentiation studies. We are in the process of derivation of functional hMd-Neurons according to hMSC subtype. Furthermore, categorization of hMd-Neurons according to their structural class, homing certain types of neurotransmitter receptors, and overall investigation of their function/tissue spesific abilities can pioneer the regenerative studies for a broad range of the nervous system deficiencies and ultimately lead to development of disease models and preclinical therapeutic approaches [45, 46] . 
